• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Cardiology

Novel cardiovascular biomarkers associated with modest discrimination in early, noninvasive diagnosis of type 2 myocardial infarction

byYuchen DaiandMichael Pratte
June 2, 2021
in Cardiology, Emergency
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. Biomarkers quantifying endothelial dysfunction, microvascular dysfunction, and/or hemodynamic stress provided modest diagnostic performance in the early discrimination of type 2 myocardial infarction (T2MI) from type 1 myocardial infarction (T1MI).

2. Given their limited clinical significance, clinical parameters and diagnostic investigations including coronary angiography and/or noninvasive functional or anatomic testing currently remain the only reliable means for timely identification of patients with T2MI.

Evidence Rating Level: 2 (Good)

Study Rundown: Myocardial infarction (MI) is one of the most common causes of death worldwide. Two different pathophysiological mechanisms underlie spontaneously occurring MI: T1MI, which arises via plaque rupture leading to coronary atherothrombosis and T2MI, which is due to a supply-demand mismatch from impaired systemic hemodynamics. Because treatments differ substantially, the rapid and accurate noninvasive discrimination of T2MI is essential. Unfortunately, this is a major unmet clinical need, as established biomarkers of cardiomyocyte injury, including high-sensitivity cardiac troponin (hs-cTn) levels, have only modest diagnostic discrimination. This multicenter prospective diagnostic study, APACE, sought to test the hypothesis that novel cardiovascular biomarkers quantifying different pathophysiological pathways involved in T2MI and/or T1MI may aid clinicians in the rapid discrimination of T2MI from T1MI. Among 5,887 eligible patients, 1,106 (18.8%) had an adjudicated final diagnosis of MI and of these, 246 patients (22.2%) had T2MI and 860 (77.8%) had T1MI. The study reported four major findings. First, most cardiovascular biomarkers evaluated had comparable concentrations between T2MI and T1MI and thus, were not helpful in their discrimination. Second, four novel biomarkers were higher in T2MI vs T1MI and showed modest promise for the early discrimination of T2MI (MR-proANP, CT-proET-1, midregional proadrenomedullin, and GDF 15). Third, cMyC concentrations, considered to quantify cardiomyocyte injury, were lower in T2MI vs T1MI and provided modest diagnostic accuracy, comparable with that provided by hs-cTnT and hscTnI. Lastly, while none of the tested cardiovascular biomarkers had significantly higher diagnostic discrimination, multivariable regression analysis suggested a possible additive value of MR-proANP to clinical variables. In summary, novel cardiovascular biomarkers provided modest diagnostic performance in the early detection of T2MI from T2MI. A limitation of this study was the number of patients in whom all (or most) novel biomarkers could be measured, as the cohort size was underpowered to allow for full comparison of diagnostic performance and assessment on the use of multiple biomarker combinations.

Click to read the study in JAMA Cardiology

Click to read an editorial in JAMA Cardiology

Relevant Reading: Cardiac troponin changes to distinguish type 1 and type 2 myocardial infarction and 180-day mortality risk

RELATED REPORTS

Improved mortality rates for myocardial infarction, stroke, and pulmonary embolism in patients receiving dialysis between 1998 to 2015

Ophthalmologic procedures are not associated with increased risk for acute myocardial infarction

Clinically important troponin I threshold for mortality after cardiac surgery

In-Depth [prospective cohort]: This international, multicenter prospective diagnostic study was conducted in 12 emergency departments in 5 countries (Switzerland, Spain, Italy, Poland, and Czech Republic) with patients presenting with acute chest discomfort. Exclusion criteria included patients with end-stage kidney failure receiving dialysis, patients presenting with ST-elevation MI (rare presentation in T2MI), and patients with an unclear final diagnosis despite elevated hs-cTn concentrations. The study sought to quantify the discrimination of hs-cTn T, hs-cTn I, as well as 17 novel biomarkers measured in subsets of consecutively enrolled patients against the reference standard (final adjudicated diagnosis), centrally adjudicated by two independent cardiologists. Among 5,887 patients, 1,106 (18.8%) had a final diagnosis of MI and of these, 860 patients (77.8%) had T1MI, and 246 (22.2%) had T2MI. When compared to patients with T1MI, patients with T2MI had lower concentrations of biomarkers indicative of cardiomyocyte injury including hs-cTnT (median [IQR], 30 [17-55] ng/L vs 58 [28-150] ng/L), hs-cTnI (23 [10-83] ng/L vs 115 [28-576] ng/L; P < .001), and cMyC (76 [38-189] ng/L vs 257 [75-876] ng/L; P < .001). However, T2MI patients had higher concentrations of biomarkers quantifying endothelial dysfunction, microvascular dysfunction, and/or hemodynamic stress (median [IQR] values: CT-proET-1, 97 [75-134] pmol/L vs 68 [55-91] pmol/L; midregional proadrenomedullin, 0.97 [0.67-1.51] pmol/L vs 0.72 [0.53-0.99] pmol/L; MR-proANP, 378 [207-491] pmol/L vs 152 [90-247] pmol/L; and GDF 15, 2.26 [1.44-4.35] vs 1.56 [1.02-2.19] ng/L; all P < .001). Discrimination for these biomarkers, as quantified by the area under the receiver operating characteristics curve, was modest (hs-cTnT, 0.67 [0.64-0.71]; hs-cTn I, 0.71 [0.67-0.74]; cMyC, 0.67 [0.61-0.73]; CT-proET-1, 0.73 [0.63-0.83]; midregional proadrenomedullin, 0.66 [0.60-0.73]; MR-proANP, 0.77 [0.68-0.87]; and GDF 15, 0.68 [0.58-0.79]; all 95% CI).
* cMyC = cardiac myosin-binding protein C, CT-proET-1 = C-terminal proendothelin 1, MR-proANP = midregional pro–A-type natriuretic peptide, GDF 15 = growth differentiation factor 15

Image: PD

©2021 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: acute myocardial infarctionbiomarkersmyocardial infarction
Previous Post

COVID-19 in pregnancy associated with substantially increased maternal and neonatal morbidity and mortality

Next Post

Young adult patients recovering from COVID-19 might be at increased risk of acute ischemic stroke

RelatedReports

Fish oil and aspirin did not reduce arteriovenous fistula failure: The FAVOURED trail
Cardiology

Improved mortality rates for myocardial infarction, stroke, and pulmonary embolism in patients receiving dialysis between 1998 to 2015

April 22, 2022
Nonpowder gun-related pediatric eye injuries on the rise
Cardiology

Ophthalmologic procedures are not associated with increased risk for acute myocardial infarction

April 22, 2022
30-Day mortality decreased in UK pediatric cardiac surgery from 2000-2010
Cardiology

Clinically important troponin I threshold for mortality after cardiac surgery

March 8, 2022
Quick Take: Efficacy of prehospital criteria in identifying trauma patients susceptible to undertriage
Cardiology

Biomarkers demonstrate neuroprognostic accuracy for patients with hypoxic ischemic brain injury following cardiac arrest

April 7, 2022
Next Post
Intensive rehabilitation not superior to traditional therapy for arm function after stroke

Young adult patients recovering from COVID-19 might be at increased risk of acute ischemic stroke

Decreased expression of nasal ACE2 may be correlated with lower prevalence of COVID-19 in children

Social vulnerability influences coronavirus disease 2019 outcomes in major cities

Medical vaccine exemptions increase after elimination of nonmedical exemptions

Nationwide mass vaccination highly effective against coronavirus disease 2019

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

Get 2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Early onset Lewy Body Dementia is more clinically distinct from Alzheimer Dementia than late onset Lewy Body Dementia
  • Pelvic lymph node radiotherapy and androgen deprivation therapy augment progression-free status following prostatectomy
  • Operating the day after performing surgery the previous night not associated with adverse patient outcomes
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.